Notice Information
Notice Title
Erythropoietin Stimulating Agents and Sevelamer
Notice Description
This Framework Agreement is awarded for the supply of a range of Erythropoietin Stimulating Agents and Sevelamer to Health Boards across NHS Scotland and the provision of a Home Delivery Service for the delivery of Erythropoietin Stimulating Agents Medicines to patient homes across NHS Scotland. The framework agreement is awarded as a single supplier framework on a line by line basis for each product line.
Lot Information
Supply of Sevelamer Medicines
This framework agreement is awarded for the supply of Sevelamer Hydrochloride 800mg tablets, Sevelamer Carbonate 800mg tablets, and Sevelamer Carbonate 2.4G powder for oral suspension to NHS Scotland. Each product line is treated as an individual Lot and is awarded on a line by line basis. Each Lot is awarded as a single supplier framework agreement.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement by up to a further two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension.
Supply of Erythropoietin Stimulating Agents for Hospital UseThis Framework Agreement is awarded for the supply of the range of Erythropoietin Stimulating Agents to Health Boards across NHS Scotland. Each product line is treated as an individual Lot and is awarded on a line by line basis. Each Lot is awarded as a single supplier framework agreement.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement by up to a further two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension.
Homecare supply of Erythropoietin Stimulating AgentsThis Framework Agreement is awarded for the supply of the range of Erythropoietin Stimulating Agents supplied by homecare delivery to patients across NHS Scotland. Each product line is treated as an individual Lot and is awarded on a line by line basis. Each Lot is awarded as a single supplier framework agreement.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement by up to a further two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-r6ebe6-0000502199
- Publication Source
- Public Contracts Scotland
- Latest Notice
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=DEC302925
- Current Stage
- Award
- All Stages
- Tender, Award
Procurement Classification
- Notice Type
- OJEU - F3 - Contract Award Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
33696100 - Blood-grouping reagents
Notice Value(s)
- Tender Value
- £8,120,000 £1M-£10M
- Lots Value
- £8,129,400 £1M-£10M
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 30 Nov 20178 years ago
- Submission Deadline
- 24 Oct 2017Expired
- Future Notice Date
- Not specified
- Award Date
- 20 Nov 20178 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Complete
- Awards Status
- Not Specified
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY")
- Contact Name
- Brian Roach - NDC Commodity Manager, Kris Lindsay, Commodity Manager, Mairi Gibson
- Contact Email
- brian.roach@nhs.net, kris.lindsay@nhs.net, mairi.gibson@nhs.net
- Contact Phone
- +44 1312757454, +44 161312757620, +44 1698794544
Buyer Location
- Locality
- EDINBURGH
- Postcode
- EH12 9EB
- Post Town
- Edinburgh
- Country
- Scotland
-
- Major Region (ITL 1)
- TLM Scotland
- Basic Region (ITL 2)
- TLM1 East Central Scotland
- Small Region (ITL 3)
- TLM13 City of Edinburgh
- Delivery Location
- TLM Scotland
-
- Local Authority
- City of Edinburgh
- Electoral Ward
- Drum Brae/Gyle
- Westminster Constituency
- Edinburgh South West
Further Information
Notice Documents
-
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP296328
Erythropoietin Stimulating Agents and Sevelamer - This Framework Agreement is for the supply of a range of Erythropoietin Stimulating Agents and Sevelamer to Health Boards across NHS Scotland and the provision of a Home Delivery Service for the delivery of Erythropoietin Stimulating Agents Medicines to patient homes across NHS Scotland. The framework agreement will be awarded as a single supplier framework on a line by line basis for each product line. Additional information is available in the tender documentation. -
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=DEC302925
Erythropoietin Stimulating Agents and Sevelamer - This Framework Agreement is awarded for the supply of a range of Erythropoietin Stimulating Agents and Sevelamer to Health Boards across NHS Scotland and the provision of a Home Delivery Service for the delivery of Erythropoietin Stimulating Agents Medicines to patient homes across NHS Scotland. The framework agreement is awarded as a single supplier framework on a line by line basis for each product line.
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-r6ebe6-0000502199-2017-11-30T00:00:00Z",
"date": "2017-11-30T00:00:00Z",
"ocid": "ocds-r6ebe6-0000502199",
"initiationType": "tender",
"parties": [
{
"id": "org-15",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
},
"address": {
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
"locality": "Edinburgh",
"region": "UKM",
"postalCode": "EH12 9EB"
},
"contactPoint": {
"name": "Mairi Gibson",
"email": "mairi.gibson@nhs.net",
"telephone": "+44 1698794544",
"url": "http://www.publictendersscotland.publiccontractsscotland.gov.uk"
},
"roles": [
"buyer",
"centralPurchasingBody",
"reviewBody"
],
"details": {
"classifications": [
{
"id": "Body governed by public law",
"scheme": "TED_CA_TYPE"
},
{
"id": "07",
"description": "Health",
"scheme": "COFOG"
}
],
"url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
}
},
{
"id": "org-2",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
},
"address": {
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
"locality": "Edinburgh",
"region": "UKM",
"postalCode": "EH12 9EB"
},
"contactPoint": {
"name": "Brian Roach - NDC Commodity Manager",
"email": "brian.roach@nhs.net",
"telephone": "+44 161312757620",
"url": "http://"
},
"roles": [
"buyer"
],
"details": {
"url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
}
},
{
"id": "org-14",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
},
"address": {
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
"locality": "Edinburgh",
"region": "UKM",
"postalCode": "EH12 9EB"
},
"contactPoint": {
"name": "Kris Lindsay, Commodity Manager",
"email": "kris.lindsay@nhs.net",
"telephone": "+44 1312757454",
"url": "http://"
},
"roles": [
"buyer",
"centralPurchasingBody",
"reviewBody"
],
"details": {
"classifications": [
{
"id": "Body governed by public law",
"scheme": "TED_CA_TYPE"
},
{
"id": "07",
"description": "Health",
"scheme": "COFOG"
}
],
"url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
}
}
],
"buyer": {
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
"id": "org-14"
},
"tender": {
"id": "NP40717",
"title": "Erythropoietin Stimulating Agents and Sevelamer",
"description": "This Framework Agreement is awarded for the supply of a range of Erythropoietin Stimulating Agents and Sevelamer to Health Boards across NHS Scotland and the provision of a Home Delivery Service for the delivery of Erythropoietin Stimulating Agents Medicines to patient homes across NHS Scotland. The framework agreement is awarded as a single supplier framework on a line by line basis for each product line.",
"status": "complete",
"items": [
{
"id": "1",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "1"
},
{
"id": "2",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
},
{
"id": "33696100",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "2"
},
{
"id": "3",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "3"
}
],
"value": {
"amount": 8120000,
"currency": "GBP"
},
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"mainProcurementCategory": "goods",
"submissionMethod": [
"electronicSubmission"
],
"submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk",
"tenderPeriod": {
"endDate": "2017-10-24T12:00:00Z"
},
"awardPeriod": {
"startDate": "2017-10-24T12:00:00Z"
},
"documents": [
{
"id": "SEP296328",
"documentType": "contractNotice",
"title": "Erythropoietin Stimulating Agents and Sevelamer",
"description": "This Framework Agreement is for the supply of a range of Erythropoietin Stimulating Agents and Sevelamer to Health Boards across NHS Scotland and the provision of a Home Delivery Service for the delivery of Erythropoietin Stimulating Agents Medicines to patient homes across NHS Scotland. The framework agreement will be awarded as a single supplier framework on a line by line basis for each product line. Additional information is available in the tender documentation.",
"url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP296328",
"format": "text/html"
},
{
"id": "DEC302925",
"documentType": "awardNotice",
"title": "Erythropoietin Stimulating Agents and Sevelamer",
"description": "This Framework Agreement is awarded for the supply of a range of Erythropoietin Stimulating Agents and Sevelamer to Health Boards across NHS Scotland and the provision of a Home Delivery Service for the delivery of Erythropoietin Stimulating Agents Medicines to patient homes across NHS Scotland. The framework agreement is awarded as a single supplier framework on a line by line basis for each product line.",
"url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=DEC302925",
"format": "text/html"
}
],
"lots": [
{
"id": "1",
"title": "Supply of Sevelamer Medicines",
"description": "This framework agreement is awarded for the supply of Sevelamer Hydrochloride 800mg tablets, Sevelamer Carbonate 800mg tablets, and Sevelamer Carbonate 2.4G powder for oral suspension to NHS Scotland. Each product line is treated as an individual Lot and is awarded on a line by line basis. Each Lot is awarded as a single supplier framework agreement.",
"status": "complete",
"value": {
"amount": 342000,
"currency": "GBP"
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed",
"electronicCataloguePolicy": "required"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "The Authority is entitled at its sole discretion to extend the Framework Agreement by up to a further two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension."
}
},
{
"id": "2",
"title": "Supply of Erythropoietin Stimulating Agents for Hospital Use",
"description": "This Framework Agreement is awarded for the supply of the range of Erythropoietin Stimulating Agents to Health Boards across NHS Scotland. Each product line is treated as an individual Lot and is awarded on a line by line basis. Each Lot is awarded as a single supplier framework agreement.",
"status": "complete",
"value": {
"amount": 5875000,
"currency": "GBP"
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "The Authority is entitled at its sole discretion to extend the Framework Agreement by up to a further two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension."
}
},
{
"id": "3",
"title": "Homecare supply of Erythropoietin Stimulating Agents",
"description": "This Framework Agreement is awarded for the supply of the range of Erythropoietin Stimulating Agents supplied by homecare delivery to patients across NHS Scotland. Each product line is treated as an individual Lot and is awarded on a line by line basis. Each Lot is awarded as a single supplier framework agreement.",
"status": "complete",
"value": {
"amount": 1912400,
"currency": "GBP"
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "The Authority is entitled at its sole discretion to extend the Framework Agreement by up to a further two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension."
}
}
],
"lotDetails": {
"maximumLotsBidPerSupplier": 2147483647
},
"bidOpening": {
"date": "2017-10-24T12:00:00Z"
},
"contractTerms": {
"hasElectronicPayment": true,
"hasElectronicOrdering": true,
"electronicInvoicingPolicy": "allowed"
},
"coveredBy": [
"GPA"
],
"selectionCriteria": {
"criteria": [
{
"type": "suitability",
"description": "Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015."
},
{
"type": "technical",
"description": "Lot 1 and Lot 2: (a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by approved by the MHRA for all tendered Medicines at the date of submission of the tender. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent. Lot 3: (a) All of the goods supplied under the framework agreement must be stored in and distributed from a site holding an MHRA Wholesaler Dealers Authorisation which covers POM medicines. (b) All of the dispensed Goods supplied under the framework agreement will be dispensed in a pharmacy which at the time of dispensing is registered with the General Pharmaceutical Council. (c) All of the Pharmacist and Pharmacy Technician staff used to service this framework agreement will be registered with the General Pharmaceutical Council. (d) The successful Framework Participant and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent. (e) All of the direct patient contact will be undertaken by staff, including all sub-contractors and couriers that, at the point of service provision, have Protecting Vulnerable Groups Scheme clearance in accordance with the prevailing regulations.",
"minimum": "Lot 1 and Lot 2: (a) Confirmation of existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes. Lot 3: (a) Confirmation of the storage and distribution site(s)' MHRA Wholesaler Dealers Authorisation registration certificate, together with, in the event that the economic operator would sub-contract the storage and distribution of the medicines to any third party holder of such a certificate, a \"To Whom It May Concern\" letter from the certificate holder confirming that the certificate holder is (or intends to be) party to a contract with the economic operator in terms of which the certificate holder may be required by the economic operator to store and distribute all the medicines which NHS Scotland may require to be supplied in terms of the framework agreement. (b) Confirmation of the dispensing site(s)' General Pharmaceutical Council registration certificate, together with, in the event that the economic operator would sub-contract the dispensing of the medicines to any third party holder of such a certificate, a \"To Whom It May Concern\" letter from the certificate holder confirming that the certificate holder is (or intends to be) party to a contract with the economic operator in terms of which the certificate holder may be required by the economic operator to dispense all medicines which NHS Scotland may require to be dispensed in terms of the framework agreement. (c) Confirmation of the Work Instructions and a description of the processes that would be in place to ensure all Pharmacists and Pharmacy Technicians employed to service this Framework Agreement were registered with the General Pharmaceutical Council. (d) Confirmation of the existence of a valid certification of BS EN ISO 9001 or equivalent. (e) Confirmation of Work Instructions and a description of the processes that would be in place to ensure all staff with direct patient contact had Protecting Vulnerable Groups Scheme clearance at the time of service provision."
}
]
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"durationInDays": 90
}
},
"techniques": {
"hasFrameworkAgreement": true
},
"classification": {
"id": "33600000",
"scheme": "CPV"
},
"reviewDetails": "The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
"hasRecurrence": false,
"amendments": [
{
"id": "amd-8",
"description": "Dates changed to allow additional time for suppliers to review clarifications recently published",
"unstructuredChanges": [
{
"oldValue": {
"date": "2017-10-24T12:00:00Z"
},
"newValue": {
"date": "2017-10-27T12:00:00Z"
},
"where": {
"section": "IV.2.2",
"label": "Time limit"
}
},
{
"oldValue": {
"date": "2017-10-24T12:00:00Z"
},
"newValue": {
"date": "2017-10-27T12:00:00Z"
},
"where": {
"section": "IV.2.7",
"label": "Conditions for opening of tenders"
}
}
]
}
]
},
"language": "EN",
"description": "The estimated value range referred to in Sections II.I.7 and V.2.4 (Lot 1, Lot 2 and Lot 3) covers the twenty four (24) months initial duration and the full two (2) periods of twelve (12) month extension options. (SC Ref:520780)",
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000502199"
},
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000502199"
},
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000502199"
}
],
"noticetype": "OJEU - F3 - Contract Award Notice",
"awards": [
{
"id": "NP40717-1",
"title": "Supply of Sevelamer Medicines",
"relatedLots": [
"1"
]
},
{
"id": "NP40717-2",
"title": "Supply of Erythropoietin Stimulating Agents for Hospital Use",
"relatedLots": [
"2"
]
},
{
"id": "NP40717-3",
"title": "Homecare supply of Erythropoietin Stimulating Agents",
"relatedLots": [
"3"
]
}
],
"contracts": [
{
"id": "NP40717-1",
"awardID": "NP40717-1",
"title": "Supply of Sevelamer Medicines",
"status": "active",
"dateSigned": "2017-11-20T00:00:00Z"
},
{
"id": "NP40717-2",
"awardID": "NP40717-2",
"title": "Supply of Erythropoietin Stimulating Agents for Hospital Use",
"status": "active",
"dateSigned": "2017-11-20T00:00:00Z"
},
{
"id": "NP40717-3",
"awardID": "NP40717-3",
"title": "Homecare supply of Erythropoietin Stimulating Agents",
"status": "active",
"dateSigned": "2017-11-20T00:00:00Z"
}
],
"relatedProcesses": [
{
"id": "1",
"relationship": [
"planning"
],
"scheme": "EU-OJ",
"identifier": "2017/S 183-374653"
}
]
}